Department of Nutritional Sciences and Toxicology

The California Institute for Quantitative Sciences QB3-BerkeleyDepartment of Nutritional Sciences and Toxicology

NeuroAge Therapeutics is a longevity biotech company based in San Francisco that targets brain aging to treat neurodegenerative diseases. Our drug discovery platform utilizes aging clocks in human brain and patient derived-neurons. We also have the first multi-omic diagnostic test for brain aging, which will be a companion diagnostic for our therapeutics. You can sign up for the waitlist for the NeuroAge Test at neuroagetx.com.

* Thesis titled "Targeting Intrinsically Disordered Proteins (IDPs) associated with neurodegenerative diseases: A strategy towards drug discovery" * Awarded Salje Medal for the best PhD in Sciences 2015 at Clare Hall, University of Cambridge* Supervisor: Prof Michele Vendruscolo

BioSakshat, Inc. featured in the National Academy of Sciences, India's Trailblazers: Mapping the Journey of Young Bioentrepreneurs link: http://www.nasi.org.in/TRAILBLAZERS%20(Mapping%20the%20Journey%20of%20Young%20Bioentrepreneurs).PDFWebsite: http://biosakshat.weebly.comAn academic/social initiative with a vision of empowering education and research in life sciences through various activities such as workshops, lectures, seminars, competitions, scientific social networking, science outreach and much more.

-Studied the modulation of host proteome by Leishmania donovani-Characterized Aquaporin-like protein. NCBI GeneBank sequence: GU199597.1

Phylodynamics of HIV-1 in Europe and Africa; estimating selection pressures using Maximum Likelihood and Bayesian Methods.

Structural Variations in the Yeast genome

Cloning and bioinformatics analyses of aquaporins (AQP) from Leishmania donovani